Connect Biopharma Holdings (CNTB) Payables (2020 - 2026)

Connect Biopharma Holdings has disclosed Payables across 7 years of filings, most recently posting $2.0 million for Q2 2026.

• In Q2 2026, Payables fell 12.12% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $2.0 million (down 12.12% YoY), while the FY2025 annual figure was $2.0 million, up 474.27% from the prior year.
• Payables came in at $2.0 million for Q2 2026 at Connect Biopharma Holdings, down from $4.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $15.4 million in Q2 2022 to a low of $342000.0 in Q4 2024.
• Average Payables over 5 years is $5.1 million, with a median of $2.3 million recorded in 2023.
• Year-over-year, Payables tumbled 84.52% in 2024 and soared 474.27% in 2025.
• Over 5 years, Payables stood at $11.7 million in 2022, then tumbled by 81.1% to $2.2 million in 2023, then plunged by 84.52% to $342000.0 in 2024, then soared by 474.27% to $2.0 million in 2025, then climbed by 2.65% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $2.0 million in Q2 2026, $4.3 million in Q1 2026, and $2.0 million in Q4 2025.